Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration
- PMID: 10405156
- DOI: 10.1016/s0014-5793(99)00685-7
Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration
Abstract
The deposition of beta-amyloid peptide (A beta), the hyperphosphorylation of tau protein and the death of neurons in certain brain regions are characteristic features of Alzheimer's disease. It has been proposed that the accumulation of aggregates of A beta is the trigger of neurodegeneration in this disease. In support of this view, several studies have demonstrated that the treatment of cultured neurons with A beta leads to the hyperphosphorylation of tau protein and neuronal cell death. Here we report that lithium prevents the enhanced phosphorylation of tau protein at the sites recognized by antibodies Tau-1 and PHF-1 which occurs when cultured rat cortical neurons are incubated with A beta. Interestingly, lithium also significantly protects cultured neurons from A beta-induced cell death. These results raise the possibility of using chronic lithium treatment for the therapy of Alzheimer's disease.
Similar articles
-
Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease.Bipolar Disord. 2002 Jun;4(3):153-65. doi: 10.1034/j.1399-5618.2002.01150.x. Bipolar Disord. 2002. PMID: 12180271 Review.
-
Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.J Neurosci Res. 2011 Mar;89(3):437-47. doi: 10.1002/jnr.22563. Epub 2010 Dec 17. J Neurosci Res. 2011. PMID: 21259330
-
Amyloid-β Modulates Both AβPP and Tau Phosphorylation.J Alzheimers Dis. 2015;45(2):495-507. doi: 10.3233/JAD-142664. J Alzheimers Dis. 2015. PMID: 25589714
-
Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures.Neuroscience. 2002;115(1):201-11. doi: 10.1016/s0306-4522(02)00404-9. Neuroscience. 2002. PMID: 12401334
-
Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.Curr Pharm Des. 2011;17(25):2603-12. doi: 10.2174/138161211797416093. Curr Pharm Des. 2011. PMID: 21728979 Review.
Cited by
-
How Can Insulin Resistance Cause Alzheimer's Disease?Int J Mol Sci. 2023 Feb 9;24(4):3506. doi: 10.3390/ijms24043506. Int J Mol Sci. 2023. PMID: 36834911 Free PMC article. Review.
-
Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model.Neuropsychopharmacology. 2011 Apr;36(5):1073-89. doi: 10.1038/npp.2010.245. Epub 2011 Feb 2. Neuropsychopharmacology. 2011. PMID: 21289607 Free PMC article.
-
Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses.Front Aging Neurosci. 2019 Jul 31;11:184. doi: 10.3389/fnagi.2019.00184. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31417394 Free PMC article.
-
Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3.Neuro Oncol. 2008 Oct;10(5):690-9. doi: 10.1215/15228517-2008-041. Epub 2008 Aug 20. Neuro Oncol. 2008. PMID: 18715951 Free PMC article.
-
Interacting Models of Amyloid-β and Tau Proteins: An Approach to Identify Drug Targets in Alzheimer's Disease.J Alzheimers Dis Rep. 2021 May 14;5(1):405-411. doi: 10.3233/ADR-210018. J Alzheimers Dis Rep. 2021. PMID: 34189412 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources